Predict your next investment

HEALTHCARE | Medical Devices & Equipment / Surgical Devices

See what CB Insights has to offer

Stage

Series C - IV | Alive

Total Raised

$37.55M

Last Raised

$1.5M | 22 yrs ago

About Neocrin

Researcher and developer of a minimally invasive, encapsulated cellular transplant device for the treatment of diabetes. The company sold its assets to Novocell.

Neocrin Headquarter Location

31 Technology Drive Suite 100

Irvine, California, 92618,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Neocrin

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Neocrin is included in 1 Expert Collection, including Diabetes.

D

Diabetes

1,734 items

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.